Rosuvastatin for Preventing Complications in Renal Ablation
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to test the hypothesis that twice overnight high-dose
rosuvastatin loading before RNA followed by 3-month treatment with regular doses of
rosuvastatin can reduce both the acute and late renal artery damage.